Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN103232400A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103232400A discloses a solvent-free rare earth catalyzed route for quinazoline-2-thiones, offering high yields and simplified purification for pharmaceutical intermediates.